Change text size Change text size

The Pharmaceutical Industry

Public Hearing Details

Venue and Date Participants
Sydney, 6 February 1996 Australian Pharmaceutical Advisory Council (APAC)
(Professor Lloyd Sansom)

Pharmaceutical Health and Rational use of Medicines
Committee (Professor Anthony Smith)

Eli Lilly Aust. Pty Ltd (Mark Kershisnik, Mike Swanson)

MDA PHARMA (Medical Dynamics Australia) (Darryll Cullen)

Merck, Sharp & Dohme (Lee Ausburn, Sarah Pantzer)

The Garvan Institute of Medical Research (Robert Faulkner)
   
Sydney, 7 February 1996 The Proprietary Medicines Association of Australia (PMAA)
(David Stephens, Juliet Seifert, George Brownbill [ACIL acting for PMAA])

Pfizer Pty Ltd (Allan Brindell, Gerard Cudmore, Ken Moran)

Parke Davis Pty Ltd / Parke Davis-Wellcome Consumer
Healthcare (Derek J.Tye)

Nutritional Foods Association of Australia (NFAA)
(Jenny Murphy, Val Johanson)

Cenovis Pty Ltd (Heidi Schuett)
   
Sydney, 8 February 1996 Australian Pharmaceutical Manufacturers Association (APMA)
(Merv Michell, Pat Clear, Dr Janice Hirshorn, Fiona Woodard, Mendel Grobler)

Pharmaceutical Benefits Advisory Committee (Professor Donald Birkett)

Astra Pharmaceucticals (Stephen Tyldesley)
   
Canberra, 13 February 1996 DHSH-Pharmaceutical Benefits Branch (Dr David Graham,
Andrew Mitchell, Alan Stevens, Des Threlfall, Cathy Bell)

DIST (Patricia Kelly)

Bristol-Myers Squibb (Malcolm Eppingstall)
   
Canberra, 14 February 1996 The Therapeutic Goods Administration (TGA) (Dr Geoffrey Vaughan,
Dr John McEwen, Garry James, Dr John Cable, Barry O'Shannassy)

National Drugs and Poisons Scheduling Committee (NDPSC)
(Dr Alan Black, Keith McKellar, Graham Cox)
   
Canberra, 15 February 1996 Pharmacy Guild of Australia (Stephen Greenwood, Rodney Cohen)

Pharmaceutical Society of Australia (Warrick Plunkett,
Associate Professor Peter Carroll, Bruce Jenkin)

Australian Taxation Office (ATO) (Jim Killaly)
   
Melbourne, 20 February 1996 Association of Australian Medical Research Institutes (Prof. John Mills)

CSIRO Division of Biomolecular Engineering (Dr. Simon Carroll)

Institute of Drug Technology Ltd (Dr Graeme Blackman)
   
Melbourne, 21 February 1996 Boots & Co. (David Stevens)

Prof. Peter Andrews

CSL Ltd (Dr Brian McNamee)

Australian Society of Clinical and Experimental Pharmacologists
and Toxicologists (Prof. James Angus)
   
Melbourne, 22 February 1996 SmithKline Beecham Pty Ltd (Mr Roger Fraser, Mr David Casper)

AMRAD Ltd (John Grace)

Glaxo Wellcome Ltd (Colin Armit)

Faulding Co. Ltd (Dr Ed Tweddell)